Results 241 to 250 of about 2,092,443 (297)
Substance P- and Insulin-like Growth Factor 1-derived Tetrapeptides for Neurotrophic Keratopathy Related to Leprosy: A Clinical Trial. [PDF]
Ophthalmol SciKondo S, Okano Y, Iraha S, Tokunaga S.
europepmc +1 more source
Neurokinin 1 receptor inhibition alleviated mitochondrial dysfunction <i>via</i> restoring purine nucleotide cycle disorder driven by substance P in acute pancreatitis. [PDF]
Acta Pharm Sin BHan C +14 more
europepmc +1 more source
Comparison of plasma substance P concentrations in the blood of healthy male and female German Simmental calves. [PDF]
BMC Vet ResLandinger A +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
European Journal of Pain, 2000
Substance P is considered to be an important neuropeptide in nociceptive processes. Although substance P was described more than 60 years ago, there is still controversy about its exact role in nociception. This article reviews the current knowledge about the function of substance P in pain.
Snijdelaar, D.G. +3 more
openaire +5 more sources
Substance P is considered to be an important neuropeptide in nociceptive processes. Although substance P was described more than 60 years ago, there is still controversy about its exact role in nociception. This article reviews the current knowledge about the function of substance P in pain.
Snijdelaar, D.G. +3 more
openaire +5 more sources
The International Journal of Biochemistry & Cell Biology, 2001
This article provides a brief overview of the history of substance P from its discovery in the 1930s to the present day. The development of substance P receptor agonists and antagonists, and more recently the employment of transgenic mice, provide a framework to explore the functional role of substance P.
HARRISON, SELENA, GEPPETTI, PIERANGELO
openaire +3 more sources
This article provides a brief overview of the history of substance P from its discovery in the 1930s to the present day. The development of substance P receptor agonists and antagonists, and more recently the employment of transgenic mice, provide a framework to explore the functional role of substance P.
HARRISON, SELENA, GEPPETTI, PIERANGELO
openaire +3 more sources
General and Comparative Endocrinology, 1980
Abstract Immunoreactive substance P (ISP) was measured by radioimmunoassay in acid-acetone tissue extracts in representative species of invertebrates (phyla Coelenterata and Mollusca) and of non-mammalian vertebrates (Elasmobranchii, Teleostei, Amphibia, Reptilia, Aves).
T, Creagh +4 more
openaire +2 more sources
Abstract Immunoreactive substance P (ISP) was measured by radioimmunoassay in acid-acetone tissue extracts in representative species of invertebrates (phyla Coelenterata and Mollusca) and of non-mammalian vertebrates (Elasmobranchii, Teleostei, Amphibia, Reptilia, Aves).
T, Creagh +4 more
openaire +2 more sources
Radioimmunoassay for Substance P
Nature New Biology, 1973IN 1931, Von Euler and Gaddum demonstrated the presence of a substance in extracts of brain and of intestine that causes contraction of isolated intestinal muscle in vitro and vasodilatation and hypotension in vivo1. These effects occur in the presence of atropine and hence are independent of acetylcholine.
D, Powell +4 more
openaire +2 more sources
Substance P and antinociception
Peptides, 1983Substance P (SP)-induced antinociception is still a topic of controversy. Some investigators have failed to see an antinociceptive effect of SP, particularly following intraperitoneal administration. In the present experiments SP induced significant hot plate antinociception in male mice, following intraperitoneal administration.
M E, Hall, J M, Stewart
openaire +2 more sources